Cholecystitis: Clinical Trials

8 trials for Cholecystitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 8

Follow Cholecystitis: new trials by email Literature Review of Cholecystitis trials Research Report on Cholecystitis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irrigation of Bupivacaine at the Surgical Bed for Postoperative Pain Relief After Laparoscopic Cholecystectomy for Acute Cholecystitis
Bupivacaine 0.5%, Normal Saline 0.9% - Acute Cholecystitis, Postoperative Pain
Phase 4CompletedZiauddin University642025-10-012026-10-01
The Effect of Hyoscine-n-butylbromide on Nausea and Pain in Laparoscopic Cholecystectomy
hyoscine-n-butylbromide, ondansetron, • hyoscine-n-butylbromide • ondansetron - Cholecystitis, Pain
Phase 4CompletedSaglik Bilimleri Universitesi1342020-11-152025-04-17
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Deep to Moderate NMB, Moderate to Deep NMB, Rocuronium - Cholecystitis, Endometriosis
Phase 4CompletedStony Brook University792016-12-272020-04-08
Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis
Amoxicillin clavulanic, Placebo - Acute Cholecystitis
Phase 4CompletedHospital Italiano de Buenos Aires2002014-02-012019-02-27
Vitamin C Efficacy in Reducing Post Operative Pain
Ascorbic Acid - Gallbladder Inflammation
Phase 4CompletedAmerican University of Beirut Medical Center802010-11-012012-01-09
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
tigecycline, ceftriaxone plus metronidazole - Appendicitis, Cholecystitis
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer4732005-10-012013-02-25
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
tigecycline, ceftriaxone sodium + metronidazole - Appendicitis, Cholecystitis
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer4672005-09-012013-02-25
DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study
Tracer Hybrid® Wire Guides, Tracer Metro® Direct™ Wire Guide - Pancreatitis, Cholangitis
Phase 4CompletedSoon Chun Hyang University1112005-01-012012-12-07

Narrower conditions

Cholecystitis, Acute (3)  ·  Appendicitis (2)  ·  Diverticulitis (2)  ·  Peritonitis (2)  ·  Abdominal Abscess (1)  ·  Abscess (1)  ·  Cholangitis (1)  ·  Cross Infection (1)  ·  Endometriosis (1)  ·  Intestinal Obstruction (1)  ·  Intraabdominal Infections (1)  ·  Leiomyoma (1)  ·  Nausea (1)  ·  Pain (1)

Broader conditions

Biliary Tract Diseases (8)  ·  Digestive System Diseases (8)  ·  Gallbladder Diseases (8)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (3)  ·  Cecal Diseases (2)  ·  Disease Attributes (2)  ·  Diverticular Diseases (2)  ·  Gastroenteritis (2)  ·  Infections (2)  ·  Neurologic Manifestations (2)  ·  Peritoneal Diseases (2)

Interventions

Ceftriaxone (2)  ·  Metronidazole (2)  ·  Tigecycline (2)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Ascorbic Acid (1)  ·  Butylscopolammonium Bromide (1)  ·  Lactose (1)  ·  Ondansetron (1)  ·  Rocuronium (1)  ·  Saline Solution (1)

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer (2)  ·  American University of Beirut Medical Center (1)  ·  Hospital Italiano de Buenos Aires (1)  ·  Saglik Bilimleri Universitesi (1)  ·  Soon Chun Hyang University (1)  ·  Stony Brook University (1)  ·  Ziauddin University (1)

Countries

Argentina (2)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  India (1)

Top investigators

Diego Giunta, MD (1)  ·  Ghassan Kanazi, MD (1)  ·  Ruchir Gupta, MD (1)

Results publications

PMID 20670293, PMID 22402954, PMID 22439781, PMID 26582405